Aubert, Alexandre https://orcid.org/0000-0002-2646-2284
Jung, Karen https://orcid.org/0009-0008-0349-3281
Hiroyasu, Sho https://orcid.org/0000-0002-8290-2272
Pardo, Julian https://orcid.org/0000-0003-0154-0730
Granville, David J. https://orcid.org/0000-0001-6985-2816
Article History
Accepted: 15 March 2024
First Online: 30 April 2024
Competing interests
: D.J.G. is a co-founder and chief scientific officer of viDA Therapeutics, which owns patents for and is developing inhibitors targeting granzymes as therapeutics. The remaining authors declare no competing interests.